GynMDD Add-On to Supportive Psychotherapy in Mild to Moderate Depression
Official title: Multicenter Interventional Real-world Study Evaluating the Impact of the Dietary Supplement GynMDD Administered as an add-on to Supportive Psychotherapy in Patients With Mild to Moderate Depression.
Run by Fondation FondaMental · NCT07416747 · Data updated 2026-11-12
GynMDD is being tested as an add-on to supportive psychotherapy to see if it helps adults with mild to moderate depression feel better than psychotherapy with placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 168 (estimated) |
| Sponsor | Fondation FondaMental Academic / other |
| Locations | 1 site (Créteil) |
| Status | Recruiting |
| Started | March 24, 2026 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT07416747 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with mild to moderate depression (MADRS 15–34), seeking supportive psychotherapy, and affiliated with French national health insurance.
✕Probably not a fit
Individuals with high suicidal risk, current antidepressant treatment, MADRS >34, certain medical conditions contraindicating probiotics, or those not adhering to study procedures may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, add-on study tests whether the dietary supplement GynMDD can improve depressive symptoms when combined with standard supportive psychotherapy in adults aged 18–65. Participants receive weekly psychotherapy for 8 weeks and take either GynMDD or a placebo daily, alongside regular GP visits and weekly self-assessments. The primary outcome is change in MADRS score, with secondary goals including digestive well-being and gut microbiota changes. The trial compares two groups to determine if GynMDD provides additional benefit beyond psychotherapy alone. Safety screening excludes those with high suicidal risk, current antidepressant use, or conditions contraindicating probiotics.
Why it matters
Potential benefit: If successful, participants could experience greater reduction in depressive symptoms and potential gut-health improvements when using GynMDD in addition to psychotherapy.
How similar studies have gone: Previous studies of probiotic or gut-targeted add-ons show mixed results; this trial tests a specific regimen in combination with psychotherapy for mood symptoms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 to 65 years, inclusive * The main reason for consultation is a suspected depressive episode * MADRS score between 15 and 34, indicating mild to moderate depression * No suicidal risk, defined as a score of 0 on item 10 of the MADRS scale * Body Mass Index (BMI) between 19 and 29 (inclusive) * Signed informed consent, confirming that the participant understands the purpose and requirements of the study and agrees to comply with the procedures (including scheduled supportive psychotherapy sessions) * Affiliation with the French national health insurance system or beneficiary of such coverage Exclusion Criteria: * History of severe psychiatric disorders or currently undergoing supportive psychotherapy * Confirmed suicidal risk, defined as a score between 1 and 6 on MADRS item 10 * Current treatment with antidepressants (AD) * MADRS score \> 34 * Conditions in which probiotic administration is not recommended (e.g., immunodeficiency, presence of a venous catheter) * Allergy to any component of the placebo or the GynMDD dietary supplement * Current consumption of probiotic-based dietary supplements * Recent infectious episodes that may require antibiotic therapy * Current treatment with anxiolytics * Long-term chronic anti-inflammatory treatment * Alcohol abuse, defined as a consumption of 10 standard drinks per week or more * Use of illicit drugs or substances of abuse * Inability to provide informed consent * Participation in another clinical study within the past 12 months * Pregnant or breastfeeding women * Patients without health insurance * Individuals under legal protection, guardianship, trusteeship, or any other protective measure
Where it's running
-
Hôpital Albert Chenevier 40 rue de Mesly
Créteil, France Recruiting
Study contacts
- Study coordinator: Clinical Project Manager
- Email: michelle.haddad@fondation-fondamental.org
- Phone: +3314981326
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heated yoga, sauna, or a mindfulness app for depression
This project will test whether heated yoga, sauna sessions, or a mindfulness app reduce symptoms in adults with at least moderate depression.
-
CYB003, a deuterated psilocin, for adults with major depressive disorder
This trial will test whether adding CYB003 to a current antidepressant helps reduce symptoms in adults with major depressive disorder who have not responded well to their medication.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.